Catherine Spencer steps down as CEO of Cochrane

12 March 2025

Image Catherine Spencer OBE, who served as the Cochrane Collaboration’s Chief Executive Officer since 2022, has decided to step down from the role.

Cochrane celebrates third anniversary of shared commitment to public involvement in health and social care research

11 March 2025

Image March 2025 marks the third anniversary of Cochrane’s commitment to

Music-based therapy may improve depressive symptoms in people with dementia

5 March 2025

Image A new Cochrane review has found evidence that music-based therapy may benefit people living with dementia, particularly by improving symptoms of depression. 

New AI Methods Group to spearhead adoption across four leading evidence synthesis organizations

28 February 2025

Image We are delighted to announce a new, joint Methods Group between the Cochrane

Cochrane’s partnership with WHO renewed at the 156th Executive Board

13 February 2025

Image We are pleased to announce that earlier this week, Cochrane’s status as a non-State actor (NSA) in official relations with the World Health Organization (WHO) was renewed at the 156th session of the WHO Executive Board meeting in Geneva.

Honouring Cochrane's Volunteer Translators: Bridging Language Gaps in 2024

3 February 2025

Image Honouring Cochrane's Volunteer Translators: Bridging Language Gaps in 2024 Cochrane proudly ce

Cochrane launches new feature to identify retracted publications

29 January 2025

Image New Cochrane Library feature will help Information Specialists and systematic review authors produce trustworthy evidence.

Showcase your peer review contributions on Web of Science

29 January 2025

Image Cochrane peer reviewers can now feature their peer review activity on their Web of Science profiles thanks to a new collaboration between Cochrane and Clarivate. 

Antidepressants reduce anxiety, but long-term impact remains unclear

29 January 2025

Image A new Cochrane review confirms that antidepressants effectively reduce symptoms of generalized anxiety disorder (GAD) under trial conditions, although there is limited data on long-term usage.

Calorie labelling leads to modest reductions in selection and consumption

16 January 2025

Image A new Cochrane review has found that calorie labelling of food on menus and products lea